12/4
02:02 pm
mrus
Merus N.V. (MRUS): A Bull Case Theory [Yahoo! Finance]
Low
Report
Merus N.V. (MRUS): A Bull Case Theory [Yahoo! Finance]
11/17
07:10 am
mrus
Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab [Yahoo! Finance]
Low
Report
Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab [Yahoo! Finance]